All In Biotech

Free tool

FAERS Monitor: Cancidas

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021227 or its brand name (Cancidas, Caspofungin Acetate). Reports on generic versions are filed under their own applications.

Reports

4,741

Serious

4,443

94% of reports

Hospitalization

2,047

Death reported

1,687

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective684
  • off label use252
  • death226
  • product use in unapproved indication210
  • pneumonia203
  • pyrexia197
  • septic shock197
  • sepsis192
  • febrile neutropenia170
  • multiple organ dysfunction syndrome151
  • respiratory failure131
  • renal failure129
  • drug interaction125
  • fungal infection124
  • acute kidney injury122

Reports by year received

View as table
YearReports
2004157
2005138
2006129
2007170
2008143
2009146
2010142
2011186
2012177
2013171
2014221
2015249
2016258
2017314
2018359
2019364
2020282
2021213
2022205
2023187
2024220
2025181
2026129

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,418 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
multiple organ dysfunction syndromeSignal15123.820.33,258
septic shockSignal19720.217.63,562
fungal infectionSignal12416.613.91,794
febrile neutropeniaSignal17011.49.81,603
respiratory failureSignal1318.06.7794
sepsisSignal1927.66.71,107
renal failureSignal1294.33.6327
product use in unapproved indicationSignal2103.83.3428
acute kidney injurySignal1223.53.0221
drug interactionSignal1253.52.9222
pneumoniaSignal2032.82.4234
pyrexiaSignal1972.52.2183
drug ineffectiveSignal6842.32.1536
off label use2521.31.115
death2261.21.05

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.